The efficacy and safety of teriflunomide based therapy in patients with relapsing multiple sclerosis: A meta-analysis of randomized controlled trials
详细信息 查看全文
- 作者：Min Xua ; 1 ; Xuesheng Lua ; 1 ; Jing Fangb ; jingfangsh@126.com" class="auth_mail" title="E-mail the corresponding author ; Xiaoqi Zhua ; Jie Wanga
- 关键词：Meta-analysis ; Multiple sclerosis ; Randomized controlled trial ; Teriflunomide
- 刊名：Journal of Clinical Neuroscience
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：33
- 期：Complete
- 页码：28-31
- 全文大小：627 K
文摘
- •
Current randomized controlled trials were included in this meta-analysis.
- •
Teriflunomide significantly reduces annualized relapse rates of multiple sclerosis.
- •
Teriflunomide also reduces disability progression of multiple sclerosis.
- •
Teriflunomide has a similar safety and tolerability profile to placebo.